Ankylosing Spondylitis and Eye Complications: Uveitis, Scleritis, and Vision Protection

Eye Complications of Ankylosing Spondylitis (AS)

Ankylosing spondylitis (axial spondyloarthritis) is a systemic inflammatory disease. Up to 40–50% of AS patients develop at least one episode of acute anterior uveitis (AAU) in their lifetime. Other ocular manifestations occur less frequently but require vigilance.

Key Ocular Manifestations

  • Acute Anterior Uveitis (AAU) — Most Common:
    • Unilateral (alternating), acute onset.
    • Symptoms: Eye pain, redness (circumlimbal flush), photophobia, blurred vision, tearing, headache.
    • Signs: Cells/flare in anterior chamber, keratic precipitates, fibrin, hypopyon (severe).
    • Recurrent; each episode risks structural damage (synechiae, cataract, glaucoma).
  • Scleritis: Deep, boring pain (worse at night), diffuse redness (violaceous), tenderness to palpation. Can be necrotizing (vision-threatening). Associated with systemic vasculitis.
  • Episcleritis: Milder, sectoral redness, minimal pain, self-limiting. Distinct from scleritis.
  • Retinal detachment: Rare but serious. Tractional (from chronic inflammation/fibrosis) or rhegmatogenous. Sudden floaters, flashes, curtain vision loss = emergency.
  • Glaucoma: Secondary (steroid-induced, inflammatory angle closure) or primary open-angle (increased prevalence in AS). Optic neuropathy risk.
  • Dry eye disease (Keratoconjunctivitis sicca): Common; inflammatory lacrimal dysfunction, Meibomian gland dysfunction. Gritty, burning, fluctuating vision.
  • Cataract: Accelerated by chronic inflammation and corticosteroid use (topical/systemic).

Monitoring and Management

  • Baseline ophthalmology exam at AS diagnosis.
  • Annual comprehensive eye exams (dilated) — more frequent if uveitis history.
  • Urgent evaluation for ANY new eye symptoms: Pain, redness, light sensitivity, vision change, floaters/flashes. Same-day ophthalmology access critical.
  • Uveitis treatment: Topical corticosteroids (prednisolone acetate 1%), cycloplegics (atropine/cyclopentolate), systemic/periocular steroids if severe. Biologics (TNF-α inhibitors, IL-17/23 inhibitors) reduce uveitis flares.
  • Steroid-sparing: Immunomodulators, biologics minimize cataract/glaucoma risk from chronic steroids.

Patient Action Plan

  • Know your uveitis symptoms — act fast.
  • Carry steroid drops if prescribed for self-initiation at flare onset (per protocol).
  • Report eye symptoms to rheumatologist AND ophthalmologist.
  • Adhere to AS treatment — systemic control = ocular control.
  • Protect eyes: UV sunglasses, safety glasses, hydration, humidifier.

Eye involvement in AS is common, recurrent, and vision-threatening if neglected. Proactive monitoring and rapid treatment preserve sight.

Eye & Vision Disorders - Related Articles